000			01655nam a2200217Ia 4500
003			OSt
005			20251206080844.0
008			201216b2016 ||||| |||| 00| 0 eng
040			_cNLS
100			_aNalini Kaushik
245		0	_aPharmaceutical Drug Price Regulations : _bAn Analysis of Determinants of Access to Medicines
260			_aBangalore _bNLSIU _c2016
300			_a75p
505			_aContents Acknowledgement; Abbreviations; List of tables; 1 Introduction; 2 Methodology; 2.1 Purpose of the study and objectives; 2.2 Axial Research Problem; 2.3 Rationale for the study; 2.4 Research Questions; 2.5 Methodology; 2.6 Sources of Data; 3 Review of literature; 3.1 Introduction; 3.2 Understanding access; 3.3 Why access to medicines is an issue in India?; 3.4 History of price control policy in India; 3.5 Conclusion; 4 Economics of Pharmaceutical Markets; 4.1 Introduction; 4.2 Nature of Pharmaceutical Markets; 4.3 Determining Prices; 4.4 Drug Pricing Mechanism; 5 Findings: Market Impact of DPCO 2013; 5.1 Introduction; 5.2 Indian pharmaceutical market: Current scenario; 5.3 Market impact of DPCO 2013; 5.4 Conclusion; 6 Critical Discourse Analysis of NPPP 2012; 7.1 Conclusion; 7.2 Recommendations; 7.3 Future Research; 7.4 Limitations of the study; Appendix; (i) Pictures depicting functioning of RNMSC; (ii) Glossary; References
650			_aAccess to Medicines - India
650			_aEconomics of Pharmaceutical Market - India
650			_aPharmaceutical Market - India
700			_aProf. Shamnad Basheer - Guide
856			_uhttps://dans.nls.ac.in/handle/123456789/146
942			_cDIS _2ddc
999			_c114843 _d114843